The third batch of funding approvals by the Board (see GFO article) included two TB/HIV grants from Zambia. In this article, we report on the comments from the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) on the funding requests from which these grants emanated.

Among the grants approved by the Board in the third batch of funding (see GFO article) were four TB/HIV grants to Mozambique. In this article, we report on the comments of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) on the funding request from which these grants emanated.

A further $50 million was proposed in prioritized above allocation requests

In funding requests submitted to the Global Fund in Window 1 (20 March 2017) and Window 2 (23 May 2017), more than $100 million was proposed for adolescent girls and young women (AGYW). This calculation includes both allocation amounts and matching funds. In addition, more than $50 million was proposed for AGYW in prioritized above allocation requests.

Tanzania has requested $703.4 million from the Global Fund for its HIV, TB and malaria programs as well as for building resilient and sustainable systems for health (RSSH). The country submitted an integrated TB/HIV funding request as well as a malaria/RSSH request, both on 23 May 2017. The TB/HIV funding request was for $426.3 million, of which $38.4 million was a prioritized above allocation request (PAAR).

$55 million in catalytic funding is available to support HIV programmes among adolescent girls and young women in 13 countries

For the first time, gender equality is included as a top-line strategic objective in the Global Fund’s Strategy (2017-2022). HIV prevention among adolescent girls and young women (AGYW) in sub-Saharan Africa will be a strong focus for the Global Fund in the coming funding cycle (2017-2019).